This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Copyright Permission Google Scholar Articles by Sundaram, K. Articles by Reddy, S. V. PubMed PubMed Citation Articles by Sundaram, K. Articles by Reddy, S. V.

FGF-2 Stimulation of RANK Ligand Expression in Paget’s Disease of Bone

Charles P. Darby Children’s Research Institute (K.S., S.Y., S.V.R.), Medical University of South Carolina, Charleston, South Carolina 29425; Bristol Myers Squibb Pharmaceuticals (J.S.), Syracuse, New York 13057; and Henry Ford Hospital (S.R.), Detroit, Michigan 48202

Address all correspondence and requests for reprints to: Sakamuri V. Reddy, Ph.D., Charles P. Darby Children’s Research Institute, 173 Ashley Avenue, Charleston, South Carolina 29425. E-mail: reddysv{at}musc.edu.

Receptor activator for nuclear factor-B ligand (RANKL), a critical osteoclastogenic factor expressed in marrow stromal/preosteoblast cells is up-regulated in Paget’s disease of bone (PDB). We previously demonstrated that heat-shock factor-2 (HSF-2) is a downstream target of fibroblast growth factor-2 (FGF-2) signaling to induce RANKL expression in bone marrow stromal/preosteoblast cells. In this study, we identified a 2.5-fold increase in serum FGF-2 levels in patients (n = 8) with PDB compared with normal subjects (n = 10). We showed that HSF-2 co-immunoprecipitates with heat-shock protein-27 (HSP-27) and that FGF-2 stimulation significantly increased phospho-HSP-27 levels in marrow stromal cells. Confocal microscopy revealed HSF-2 colocalization with HSP-27 in unstimulated cells and HSF-2 nuclear translocation upon FGF-2 stimulation. We further show that FGF-2 stimulation significantly increased the levels of phosphorylated signal transducers and activators of the transcription (p-STAT-1) in these cells. Western blot analysis confirmed that small interfering RNA suppression of STAT-1 significantly decreased (3.2-fold) RANKL expression and promoter activity in FGF-2-stimulated cells. Chromatin immunoprecipitation assay revealed STAT-1 binding to a putative motif located far upstream (–8 kb) in the hRANKL gene promoter region. These results suggest STAT-1 is a downstream effector of FGF-2 signaling and that elevated levels of FGF-2 stimulates RANKL expression in PDB.